MedPath

Blood Pressure Measurement Methods and Prediction of Intracranial Hemorrhage After Thrombectomy in Stroke

Not Applicable
Active, not recruiting
Conditions
Acute Stroke
Cerebral Hemorrhage
Blood Pressure
Interventions
Device: Clearsight device (Edwards) around the finger
Device: Intermittent blood pressure measurements with cuff.
Registration Number
NCT03359434
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

A monocentric, non-randomized, prospective study in which each patient is his/her own control.

The study investigates 2 methods of blood pressure measurement, within the first 24 hours after reperfusion, i) Continuous measurement of blood pressure with the Clearsight device (Edwards) and ii) intermittent blood pressure measurements with cuff.

Detailed Description

Patients will be followed for 72 hours:

* inclusion after reperfusion: clinical evaluation with NIHSS (National Institute of Health Stroke Score) score, measurement of blood pressure.

* within 24 hours after reperfusion: blood pressure measurements

* at 24 hours: NIHSS score.

* Between 24 and 36 hours :cerebral scan (assessment of hemorrhagic transformations and cerebral infarction volumes).

* 72 hours after reperfusion: brain scanner in case of hyperdensity on the initial scanner

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
355
Inclusion Criteria
  • Occlusion of internal carotid arteries or proximal middle cerebral arteries (segment M1).
  • Reperfusion after a thrombectomy procedure (defined by a 2b-3 Thrombolysis In Cerebral Infarction (TICI) score).
Exclusion Criteria
  • Per-procedure hemorrhagic complications (prior to reperfusion)
  • Known pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Two measuring methods of blood pressureClearsight device (Edwards) around the finger-
Two measuring methods of blood pressureIntermittent blood pressure measurements with cuff.-
Primary Outcome Measures
NameTimeMethod
Occurence of intracranial hemorrhagic complications36 hours after baseline

number of intracranial hemorrhagic complications (symptomatic or asymptomatic) on brain scanner, evaluated with a double centralized blind reading

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondation Ophtalmologique A de Rothschild

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath